Live Cell Imaging Market Worth $2.9 Billion by 2023 - Exclusive Report by MarketsandMarkets(TM)
CHICAGO, Feb. 12, 2019 /PRNewswire/ -- According to the new market research report "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023", published by MarketsandMarkets(TM), the Live Cell Imaging Market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% during the forecast period (2018-2023).
https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
Don't miss out on business opportunities in Live Cell Imaging Market
The growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research are the major factors driving the growth of the global Live Cell Imaging Market. However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.
The instruments segment accounted for the largest share of the market in 2018
On the basis of product and service, the global Live Cell Imaging Market is segmented into instruments, consumables, software, and services. In 2018, the instruments segment accounted for the largest share of the Live Cell Imaging Market. Factors such as the launch of new and advanced instruments, increasing incidence of diseases, and rising government initiatives and awareness programs for promoting cell-based research are the major factors driving the demand for Live Cell Imaging instruments.
Browse in-depth TOC on "Live Cell Imaging Market"
88 - Tables
38 - Figures
158 - Pages
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=163914483
The academic & research institutes segment is expected to grow at the highest CAGR during the forecast period
On the basis of end user, the Live Cell Imaging Market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). The academic & research institutes segment is expected to grow at a higher CAGR during the forecast period. The high growth in this segment can be attributed to the increasing focusing of academic and research institutes on strengthening their own drug discovery research programs coupled with rising government funding to support research and advancing scientific goals.
North America dominated the Live Cell Imaging Market in 2018
North America is expected to dominate the Live Cell Imaging Market in 2018. The large share of the North America Live Cell Imaging Market can primarily be attributed to the availability of government funding for life science research, drug development regulations, advances in Live Cell Imaging techniques, growth in the biotechnology and pharmaceutical industries, and the rising incidence of cancer.
Inquiry Before Buying:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=163914483
The key players in the Live Cell Imaging Market are Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
About MarketsandMarkets(TM)
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/live-cell-imaging-market.asp
Visit Our Website: https://www.marketsandmarkets.com
View original content:http://www.prnewswire.com/news-releases/live-cell-imaging-market-worth-2-9-billion-by-2023--exclusive-report-by-marketsandmarkets-300793958.html
SOURCE MarketsandMarkets
